2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers Lain Anderson TJ Bilodeau Read more
Related Practice Life Sciences & Pharma In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations. 01052021090143
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (Australia) November 11, 2025
Video / Webinar Life Sciences & Pharma Unlocking China's Precision Medicine Potential August 25, 2025
Smart Chart Life Sciences & Pharma Radiotherapeutics on the Rise: Cracking the Supply Chain Code May 16, 2025
Executive Insights MedTech Opportunity to Build a Billion-Dollar-Revenue MedTech Platform in India February 4, 2025
Executive Insights Life Sciences & Pharma Redefining Biopharma R&D Productivity: New Insights and Strategies January 9, 2025